Blau Farmaceutica (BSP:BLAU3) Inventories, Finished Goods: R$285 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:BLAU3 Blau Farmaceutica SA BSP:BLAU3
86 GF Score
Price R$9.06
GF Value R$11.22
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Blau Farmaceutica Inventories, Finished Goods?

Blau Farmaceutica BSP:BLAU3 +0.44% 86 Inventories, Finished Goods is R$285 Mil as of Jun. 2026. GuruFocus rates BSP:BLAU3 with a GF Score™ of 86/100 and a GF Value™ of R$11.22 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Blau Farmaceutica's quarterly finished goods increased from Dec. 2025 (R$265 Mil) to Mar. 2026 (R$274 Mil) and increased from Mar. 2026 (R$274 Mil) to Jun. 2026 (R$285 Mil).

Blau Farmaceutica's annual finished goods declined from Dec. 2023 (R$215 Mil) to Dec. 2024 (R$171 Mil) but then increased from Dec. 2024 (R$171 Mil) to Dec. 2025 (R$265 Mil).

Blau Farmaceutica Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Blau Farmaceutica's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Blau Farmaceutica Inventories, Finished Goods Chart

Blau Farmaceutica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.17 119.79 214.58 170.90 264.64

Blau Farmaceutica Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 224.16 227.88 264.64 274.39 285.09
BSP:BLAU3
86GF Score
Blau Farmaceutica SA BSP:BLAU3
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Blau Farmaceutica Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of R$285 Mil mean?
Blau Farmaceutica (BSP:BLAU3) has a Inventories, Finished Goods of R$285 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Blau Farmaceutica and its competitors.
Is Blau Farmaceutica's Inventories, Finished Goods too high?
Blau Farmaceutica's current Inventories, Finished Goods is R$285 Mil. Overall, Blau Farmaceutica has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Blau Farmaceutica's Inventories, Finished Goods compare to ZTS and UTHR?
Blau Farmaceutica's Inventories, Finished Goods of R$285 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Blau Farmaceutica and its competitors. Blau Farmaceutica's current Inventories, Finished Goods is R$285 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blau Farmaceutica stock overvalued right now?
Based on GuruFocus' analysis, Blau Farmaceutica (BSP:BLAU3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$11.22, compared to a current price of R$9.06 — trading 19.3% below its estimated fair value. The current Inventories, Finished Goods is R$285 Mil. Blau Farmaceutica's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Blau Farmaceutica (BSP:BLAU3), the current Inventories, Finished Goods is R$285 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Blau Farmaceutica (BSP:BLAU3) Overvalued in 2026?

Based on GuruFocus' analysis, Blau Farmaceutica stock appears to be undervalued. The current stock price of R$9.06 is trading 19.3% below its estimated GF Value™ of R$11.22. GuruFocus considers Blau Farmaceutica to be Modestly Undervalued.

Key valuation signals for BSP:BLAU3:

  • Inventories, Finished Goods: R$285 Mil
  • GF Value™: R$11.22 vs. price of R$9.06 (19.3% below fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the BSP:BLAU3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Blau Farmaceutica Business Description

Address Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.
86GF Score

Get the complete analysis for BSP:BLAU3

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$9.06
Price
R$11.22
GF Value